Understand the source comparison
Pralmorelin Same as GHRP-2 Acetate: Research Applications Comparison
Regulatory filings (Japan, EU) Listed as active ingredient in Phase II/III submissions Typically referenced in supplementary documentation only None. Same molecular entity in both cases Use the name that matches your jurisdiction's regulatory database Research
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Regulatory filings (Japan, EU)
- Listed as active ingredient in Phase II/III submissions
- Typically referenced in supplementary documentation only
- None. Same molecular entity in both cases
- Use the name that matches your jurisdiction's regulatory database
- Research literature citations
- Rarely appears in PubMed-indexed studies (fewer than 50 papers)
- Dominant identifier in over 400 published studies since 1993
- GHRP-2 acetate yields broader literature search results
- Search both terms to ensure complete coverage
- Commercial peptide sourcing
- Some suppliers list only under pralmorelin for INN compliance
- Majority of suppliers use GHRP-2 acetate as the primary SKU name
- Ordering either name from a qualified supplier yields identical product
- Verify the supplier provides CAS numbers and sequence data to confirm identity
- Certificate of Analysis labeling
- May appear as "Pralmorelin Acetate" with CAS 158861-68-8
- Typically labeled "GHRP-2 Acetate" with the same CAS number
- None. Batch purity, sequence verification, and HPLC results are identical
- Cross-reference CAS number rather than product name